Bone mineral density in women aged 25–35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation
about
Steroidal contraceptives and bone fractures in women: evidence from observational studiesSteroidal contraceptives and bone fractures in women: evidence from observational studiesMedication-induced osteoporosis: screening and treatment strategiesElagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density.Factors associated with bone mineral density in healthy African women.Reversible female contraception: current options and new developments.Contraception in women with medical problems.Update on hormonal contraception and bone density.Effects of hypogonadism on bone metabolism in female adolescents and young adults.The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women.The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate.Depot medroxyprogesterone acetate contraceptive injections and skeletal health.A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate.Adverse bone effects of medications used to treat non-skeletal disorders.The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
P2860
Q24186379-22CC07BF-9F69-4CED-BB88-5E6C0145B1C7Q24201354-3979DA20-901E-4B8D-B0AD-2DB6D6B040EBQ34389358-E885D0AB-A67F-4121-84C1-BA33425614A9Q34418066-4BE7876C-B153-4BA9-9449-E4011B4B3B73Q36041583-9C84F241-B874-4D61-949F-0B1113EEF5B4Q36759531-C3A2A87F-79E9-40E2-A156-69CBF1907B81Q37186251-E558E76B-522D-4574-81B6-7EB7605FD2E0Q37874152-07716E89-4B84-4725-BB21-0A6DC4D82AE7Q37978208-164D4162-EA47-4312-A162-20367BC99033Q38008809-36CB6835-B2D4-405D-A6C8-57F957CC7938Q38764193-021CED5E-814B-409D-905F-75ACD6AEF30BQ43082409-92F6BE34-C6F0-4B9B-89B7-828CA243B859Q45930036-FC239C77-8EA3-453D-8DC7-825A7259F873Q48332195-D4F02B37-7228-4406-A08C-AD8545ED0632Q53053716-9194BD33-23C0-4B57-A15F-C7ABEC2927AF
P2860
Bone mineral density in women aged 25–35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation
description
im Mai 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 19 May 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2006
@uk
name
Bone mineral density in women ...... very following discontinuation
@en
Bone mineral density in women ...... very following discontinuation
@nl
type
label
Bone mineral density in women ...... very following discontinuation
@en
Bone mineral density in women ...... very following discontinuation
@nl
prefLabel
Bone mineral density in women ...... very following discontinuation
@en
Bone mineral density in women ...... very following discontinuation
@nl
P2093
P1433
P1476
Bone mineral density in women ...... very following discontinuation
@en
P2093
Andrew M Kaunitz
Paul D Miller
Valerie Montgomery Rice
P356
10.1016/J.CONTRACEPTION.2006.03.010
P577
2006-05-19T00:00:00Z